drugset
drugset / Trial / NCT07165652

Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®

NCT07165652 ↗

Phase 1 Completed 54 enrolled Xentria, Inc.
RandomizedCrossoverDouble-blindOther

Summary

Study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(L), US-Humalog®, and EU-Humalog®

Timeline

Start
2025-10-13
Primary completion
2026-03-02
Completion
2026-03-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator EU-Humalog® Unknown 0.3 iu/kg Subcutaneous
Subject NKF-INS(L) Unknown 0.3 iu/kg Subcutaneous
Comparator US-Humalog® Unknown 0.3 iu/kg Subcutaneous

Indications

No indication recorded.